Today: 7 February 2026
Subscribe

NuScale Power (SMR) Stock Rockets 14% on Historic 6GW Nuclear SMR Deal — Analysts Weigh In

SMR Stock Today (Nov 6, 2025): NuScale Slides ~14% After Q3 Miss as Fluor Sets Plan to Monetize Stake by Mid‑2026

NuScale Power (NYSE: SMR) fell after hours on November 6, 2025, following a revenue miss and wider‑than‑expected loss. Separately, long‑time backer Fluor agreed to convert and monetize its remaining stake by Q2 2026. Here’s what moved SMR today, the key numbers, and what to watch next. Key takeaways (Nov 6, 2025) SMR stock price today NuScale Power’s stock fell roughly 14% after the closing bell to about $32.46, versus a prior close near $37.91. Today’s tape showed a wide range as investors digested earnings and the Fluor announcement. (Data delayed up to 15 minutes.) Reuters Earnings: what NuScale reported (Q3
6 November 2025
·
Affirm’s Rollercoaster: Profit Milestone, Insider Sell-Off & Big BNPL Bets – What’s Next for AFRM?

AFRM Stock Today (Nov 6, 2025): Affirm Jumps After Q1 FY26 Beat, Extends Amazon Deal, Sets Q2 Revenue Outlook

Published: November 6, 2025 Affirm Holdings (NASDAQ: AFRM) surged in after-hours trading on Thursday after posting stronger‑than‑expected fiscal Q1 2026 results, raising the near‑term outlook and disclosing a multi‑year extension of its U.S. agreement with Amazon. Shares traded around the low‑$70s in the evening session—roughly 9%–11% above the regular‑session close—as investors reacted to the beat‑and‑raise narrative. Benzinga+1 Key Takeaways What Happened Today After the bell, Affirm reported fiscal Q1 2026 results that beat Wall Street expectations on both the top and bottom lines. The company posted $933.3 million in revenue and GAAP EPS of $0.23, versus consensus that was looking
6 November 2025
··
Airbnb Stock Jumps on AI Upgrades and Travel Boom – Is a Bigger Rally Ahead?

Airbnb (ABNB) Stock Today — November 6, 2025: Shares Jump After Hours as Q3 Revenue Beats and Q4 Outlook Tops Estimates

Summary: Airbnb (NASDAQ: ABNB) closed lower in regular trading but spiked in after-hours after reporting Q3 2025 results that topped revenue expectations and offered an above-consensus Q4 sales outlook. Here’s everything investors need to know today, November 6, 2025. Key takeaways ABNB price action on November 6, 2025 Context: The after-hours bounce reflects investors’ relief on revenue momentum and Q4 guidance that edges past the Street, despite a modest EPS miss. Reuters+1 Q3 2025: What stood out Guidance and early Q4 signals Where growth is coming from Airbnb continues to outgrow in expansion markets relative to core geographies: Product &
6 November 2025
Alien Probe or Cosmic Relic? Interstellar Comet 3I/ATLAS Baffles Scientists (updated 27.10.2025)

Comet 3I/ATLAS News Roundup (Nov. 6, 2025): China’s Mars Orbiter Images the Interstellar Visitor, JWST Chemistry Update, and How to See It

Comet 3I/ATLAS news roundup — November 6, 2025 Today’s big development: China’s Tianwen‑1 Mars orbiter captured and released new images of the interstellar comet 3I/ATLAS (also cataloged as C/2025 N1), taken from roughly 30 million km away during the comet’s October 3 pass near Mars. China’s state outlets say the sequence shows clear cometary features and marks one of the closest probe‑based looks at the object to date. The observation doubles as a technology pathfinder for China’s upcoming Tianwen‑2 mission. State Council of China+2Xinhua News+2 What the Tianwen‑1 images add Context: ESA’s TGO produced the closest European look on Oct.
6 November 2025
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

NVO Stock Today (Nov 6, 2025): Novo Nordisk volatile as White House pricing deal reshapes GLP‑1 market—what it means for Wegovy, Ozempic and investors

Published: November 6, 2025 TL;DR: Novo Nordisk’s U.S.‑listed shares (NYSE: NVO) swung after the White House announced a pricing-and-access deal with Novo and Eli Lilly that expands Medicare coverage for anti‑obesity drugs and cuts out‑of‑pocket costs. As of 17:51 UTC (12:51 p.m. ET), NVO traded around $47.30, down ~2.4% on the day (intraday range: $46.91–$49.49; volume ~29.3M). The company confirmed a Medicare Part D pilot beginning in 2026, lower U.S. prices in Medicare/Medicaid and cash channels, and a three‑year tariff exemption—and flagged a low single‑digit drag to 2026 global sales growth. GlobeNewswire What’s moving NVO today White House deal cuts
6 November 2025
·
NYSE Skyrockets to Record Highs as AI Frenzy, Fed Rate Cut Bets Fuel Stock Surge

Why Stocks Are Down Today (Nov. 6, 2025): Tech Sell‑Off, Shutdown Data Void, and Tariff Uncertainty Hit Wall Street

Key takeaways What the market is doing right now Stocks were broadly lower midday Thursday (around 12:30 p.m. ET): the Dow was off by roughly 0.9% (~‑400 to ‑500 points), the S&P 500 down a little over 1%, and the Nasdaq nearly ‑2% as megacaps and chipmakers led declines. A live markets snapshot showed the S&P 500 near 6,710 (‑1.3%), Dow near 46,850 (‑1.0%), and Nasdaq near 23,022 (‑2.0%). AP News+1 The “why” behind today’s sell‑off 1) Tech and AI valuation hangover Wall Street’s leadership group—mega‑cap tech and AI‑exposed names—came under renewed pressure after a brief respite Wednesday. Semiconductor shares
6 November 2025
·
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Stock Today (Nov 6, 2025): NVO steadies as White House GLP‑1 pricing deal lands; $10B Metsera bidding war heats up

Date: Thursday, November 6, 2025Ticker: NVO (NYSE) At a glance: price action and catalysts Novo Nordisk stock traded around $47.36 as of 17:52 UTC, after opening at $47.75 and moving between $46.91–$49.49 on heavy volume. The tape is being driven by two big headlines: (1) a White House pricing agreement that expands access to GLP‑1 drugs across Medicare/Medicaid and a new direct‑to‑consumer channel, and (2) a $10 billion bidding battle with Pfizer for obesity‑drug startup Metsera. What changed today 1) White House pricing deal lowers GLP‑1 costs and expands coverage The administration announced a deal with Novo Nordisk and Eli
6 November 2025
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Dow Jones Today (Nov. 6, 2025): Stocks Slide as Tech Sells Off; Layoffs Surge and FAA Orders Flight Cuts Amid Shutdown

NEW YORK — Thursday, November 6, 2025. U.S. stocks fell sharply in late‑morning trading, with the Dow Jones Industrial Average down more than 400 points (≈0.9%) as renewed selling in mega‑cap tech weighed on the broader market. The Nasdaq led losses at nearly 2%, while the S&P 500 was lower by a little over 1%. Concerns over stretched AI‑linked valuations, a spike in announced layoffs, and mounting disruption from the federal shutdown kept risk appetite in check. MarketWatch+2The Wall Street Journal+2 What’s moving markets Dow Jones today: by the numbers (intraday) Biggest drags on the Dow Salesforce (CRM) and Amazon
6 November 2025
·
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Pops as White House Strikes Obesity-Drug Pricing Deal; New 20% Weight‑Loss Data Fuels Momentum — Today, November 6, 2025

Eli Lilly stock today: drivers, numbers, and what to watch for next. Key takeaways (Nov 6, 2025) Eli Lilly stock today: quote & range As of this afternoon, LLY traded near $935.89, up about 1.1%, with today’s range $916.37–$949.90 and a 52‑week range $624.00–$955.43 (values delayed up to 15 minutes). Reuters 1) The White House’s obesity‑drug deal: lower prices, broader access President Donald Trump announced deals with Eli Lilly and Novo Nordisk to reduce U.S. costs and expand coverage for in‑demand weight‑loss medicines. The plan includes Medicare coverage for obesity treatment, expected to carry $50 monthly copays for eligible beneficiaries,
6 November 2025
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir (PLTR) slips ~5.7% as new marketing & smart‑city deals land — What’s moving the stock today (Nov. 6, 2025)

Updated Nov. 6, 2025 — 16:47 UTC Live price (intraday)As of 16:47 UTC, Palantir shares trade at $177.24, roughly ‑5.7% on the day, after opening at $188.00 and ranging between $176.97–$190.94 so far. Key takeaways What happened today (Nov. 6) 1) Two partnership headlines hit before and during the session 2) Price action in context Today’s decline extends the post‑earnings valuation shake‑out seen since Tuesday despite significant beats and a strong outlook. Reuters reported Palantir’s Q4 guide above estimates and reiterated concerns from some market participants about the implied slowdown from ~63% Q3 growth to ~61% in Q4 and still‑lofty
6 November 2025
·
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Today — November 6, 2025: Price Slides as AI-Spend Scrutiny Builds; Fresh AI Database Coverage, Gartner ‘Leader’ Nod, and New OCI Partnerships in Focus

Live ORCL snapshot (Nov 6, 2025): As of 16:38 UTC, Oracle shares trade at $241.00, down about 3.7% on the day, after ranging between $239.45–$251.41 on intraday volume of ~8.0M shares. What’s moving Oracle stock today 1) Investors wrestle with the OpenAI overhang.A fresh Business Insider write‑up this morning highlights how skepticism over OpenAI’s ability to fund its sprawling, multi‑year AI compute contracts has weighed on ORCL after September’s historic spike. The piece underscores that Oracle’s 36% single‑day surge on Sept. 10—driven by mammoth AI‑cloud wins—has since faded as markets discount execution risk on those deals. Business Insider 2) Oracle’s
6 November 2025
··
Meta’s $1.5B AI Hiring Spree: Will Zuckerberg’s Talent Grab Send META Stock Soaring & Shake Up Apple’s XR Plans?

Meta (META) Stock Today: Shares Slip ~2% as Reuters Probes Scam Ads and MPA Challenges Instagram’s ‘PG‑13’ Claim — Nov 6, 2025

Updated: Nov 6, 2025, 11:37 a.m. ET Quick takeaways Meta stock at a glance (Nov 6, 2025) By late morning, META changed hands near $620.70, down $15.25 from yesterday’s close of $635.95 (‑2.4%). Intraday volume was just over 10 million shares at the time of publication, with the session low at $619.26. Meta’s market capitalization hovered near $1.85 trillion and its P/E was ~31.5. Year‑over‑year, the stock remains well above its 52‑week low ($479.80) but below the high ($796.25) set earlier this year. Reuters What’s moving Meta today 1) Reuters investigation spotlights revenue from scam ads A fresh Reuters Special
6 November 2025
1 … 2,249 2,250 2,251 2,252 2,253 … 2,716

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop